Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

MLA

Wilpe, S.van, et al. “Homologous Recombination Repair Deficient Prostate Cancer Represents an Immunologically Distinct Subtype.” Oncoimmunology, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367101480&authtype=sso&custid=ns315887.

APA

Wilpe, S. van, Simnica, D., Slootbeek, P. H. J., Ee, T. J. van, Pamidimarri Naga, S., Gorris, M. A. J., Woude, L. L. van der, Sultan, S., Koornstra, R. H., Oort, I. M. van, Gerritsen, W. R., Kroeze, L., Simons, M., Vries, I. J. M. de, & Mehra, N. (2022). Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype. Oncoimmunology.

Chicago

Wilpe, S. van, Donjete Simnica, P. H.J. Slootbeek, T.J. van Ee, S. Pamidimarri Naga, M.A.J. Gorris, L.L. van der Woude, et al. 2022. “Homologous Recombination Repair Deficient Prostate Cancer Represents an Immunologically Distinct Subtype.” Oncoimmunology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367101480&authtype=sso&custid=ns315887.